| Literature DB >> 26941230 |
Alejandro Reyes-Bermudez1, Alejandro Villar-Briones2, Catalina Ramirez-Portilla3, Michio Hidaka4, Alexander S Mikheyev5.
Abstract
Corals belong to the most basal class of the Phylum Cnidaria, which is considered the sister group of bilaterian animals, and thus have become an emerging model to study the evolution of developmental mechanisms. Although cell renewal, differentiation, and maintenance of pluripotency are cellular events shared by multicellular animals, the cellular basis of these fundamental biological processes are still poorly understood. To understand how changes in gene expression regulate morphogenetic transitions at the base of the eumetazoa, we performed quantitative RNA-seq analysis duringAcropora digitifera's development. We collected embryonic, larval, and adult samples to characterize stage-specific transcription profiles, as well as broad expression patterns. Transcription profiles reconstructed development revealing two main expression clusters. The first cluster grouped blastula and gastrula and the second grouped subsequent developmental time points. Consistently, we observed clear differences in gene expression between early and late developmental transitions, with higher numbers of differentially expressed genes and fold changes around gastrulation. Furthermore, we identified three coexpression clusters that represented discrete gene expression patterns. During early transitions, transcriptional networks seemed to regulate cellular fate and morphogenesis of the larval body. In late transitions, these networks seemed to play important roles preparing planulae for switch in lifestyle and regulation of adult processes. Although developmental progression inA. digitiferais regulated to some extent by differential coexpression of well-defined gene networks, stage-specific transcription profiles appear to be independent entities. While negative regulation of transcription is predominant in early development, cell differentiation was upregulated in larval and adult stages.Entities:
Keywords: RNA-seq; WGCNA; cell differentiation; coral development; tissue morphogenesis; transcription regulation
Mesh:
Year: 2016 PMID: 26941230 PMCID: PMC4824149 DOI: 10.1093/gbe/evw042
Source DB: PubMed Journal: Genome Biol Evol ISSN: 1759-6653 Impact factor: 3.416
FCoral development. Libraries representing blastula (PC), gastrula (G), postgastrula (S), planula (P), and adult polyps (A) were sequenced in triplicate. Following fertilization developing embryos experience a series of asymmetrical cell divisions that continue until they reach a very distinct blastula stage characteristic of “complexa” claded corals (10–12 h) known as the prawn-chip (PC). Morphogenetic movements during gastrulation (22–36 h) originates ectodermal and endodermal tissues, the blastopore becomes the oral pore (G). Dipoblastic larvae become motile resembling a rotating sphere (36–48 h) at this time cell differentiation of tissue specific lineages begins (S). Progressive elongation of the oral/aboral axis occurs (48–96 h) until larvae acquire the characteristic planula morphology (P). At this stage and under appropriate settlement clues planulae attaches to the substrate, metamorphose into an axial polyp that will originate a new colony (A). O/A within imagines represents the oral/aboral axis. *Presence/absence of Symbiodinium sp.
FStage-specific trancriptomes. To characterize stage-specific transcription profiles we kept transcripts with at least 100 counts per million in all replicates and averaged the remaining transcripts counts. Expression levels displayed differences of 3–4 orders of magnitude between minimum and maximum values (A). In all cases, while annotated sequences were slightly more abundant in the upper ranks of the distribution, noncoding transcripts concentrated in the low expression quartile (Q1) (B). Stage-specific transcription profiles reconstructed coral development, revealing two main expression clusters. The first cluster grouped PC and G and the second grouped subsequent developmental stages. S was the most distinct stage among all developmental time points (C).
GO Enrichment Summary in Complete Data Sets and Consecutive Stages Developmental Progressions
| Stagea | GO ID | Node Size | Sample Match | P Adj | Term | Ontology | |
|---|---|---|---|---|---|---|---|
| General GO enrichment | PC | GO:0043295 | 36 | 29 | 3.82.E−02 | Glutathione binding | MF |
| G | GO:0019003 | 97 | 67 | 2.81.E−02 | GDP binding | MF | |
| S | GO:0008134 | 1105 | 641 | 3.21.E−05 | Transcription factor binding | MF | |
| P | GO:0004616 | 25 | 22 | 7.30.E−03 | Phosphogluconate dehydrogenase (decarboxylating) activity | MF | |
| A | GO:0004407 | 27 | 23 | 4.82.E−02 | Histone deacetylase activity | MF | |
| GO:0004683 | 406 | 223 | 3.64.E−02 | Calmodulin-dependent protein kinase activity | |||
| PC_A | GO:0005083 | 586 | 317 | 7.20.E−03 | Small gtpase regulator activity | MF | |
| PC_S | GO:0008013 | 155 | 102 | 1.58.E−02 | Beta-catenin binding | MF | |
| PC_G_P_A | GO:0070491 | 108 | 301 | 2.51.E−03 | Repressing transcription factor binding | MF | |
| PC_S_P_A | GO:0007030 | 404 | 263 | 3.33.E−12 | Golgi organization | BP | |
| All | GO:0030258 | 677 | 416 | 9.48.E−13 | Lipid modification | BP | |
| GO:0006907 | 2,415 | 1,469 | 3.90.E−51 | Pinocytosis | |||
| GO:0006396 | 28,24 | 1,669 | 1.91.E−40 | RNA processing | |||
| aEnriched in stages shown in column. Node size = Total number of Go terms in node. Sample match = number of transcripts with GO terms associated to specific nodes. | |||||||
Enriched in stages shown in column. Node size= Total number of GO terms in node. Sample match = number of transcripts with GO terms associated to specific nodes. GO categories shown in this table were selected based on: 1) significant P values (0.05 cutoff value) and 2) evidence in the literature of their involvement in the regulation of developmental processes. A complete list of enriched GO categories can be found in supplementary file S4, Supplementary Material online.
FDifferential gene expression during developmental progressions. A peak of DEGs was identified during early developmental transitions especially in the G to S progression. This transition also showed the highest FC’s across comparisons. Annotated transcripts were more abundant during late developmental transitions and noncoding DEGs more abundant in the comparisons involving gastrulation (A and B). Nonparametric regressions (LOWESS) identified a tendency for medium and high abundant DEGs in PC and S to have lower FCs relative to G and P, respectively. Yet, medium and high abundant DEGs in G and P tended to increase FCs relative to S and A, respectively (B). Although the transition P to A spans settlement and metamorphosis, this progression reported the lowest number of DEGs as well as the lowest FC values (A and B). Overall, we observed clear differences in gene expression between early and late developmental transitions, with higher numbers of DEGs and FCs around gastrulation.
Summary of DEGs of Developmental Relevance Identified During Consecutive Developmental Progressions
| Comparison | Up in | ID | FC | Definition | |
|---|---|---|---|---|---|
| PC vs. G | PC | adi_v1.09698 | 5.17 | 1.25. E − 08 | Cadherin EGF LAG seven-pass G-type receptor 2 |
| adi_v1.01477 | 1.16 | 3.91. E − 05 | WNT inhibitory factor 1 | ||
| adi_v1.09632 | 2.46 | 2.06. E − 28 | Polycomb protein SCMH1 | ||
| adi_v1.08662 | 2.45 | 4.99. E − 06 | Cadherin EGF LAG seven-pass G-type receptor 1 | ||
| adi_v1.04586 | 2.13 | 1.24. E − 18 | Groucho | ||
| adi_v1.00777 | 6.06 | 2.69. E − 06 | Homeobox protein MOX | ||
| adi_v1.05704 | 4.31 | 1.32. E − 08 | Homeobox protein OTX | ||
| adi_v1.06807 | 4.1 | 1.69. E − 03 | SWI/SNF-related matrix-associated | ||
| adi_v1.24238 | 3.15 | 2.87. E − 38 | SWI/SNF-related matrix-associated | ||
| adi_v1.04163 | 4.93 | 1.27. E − 04 | BTB/POZ domain-containing protein 3/6 | ||
| adi_v1.03255 | 2.29 | 1.52. E − 08 | BTB/POZ domain-containing protein 9 | ||
| G | adi_v1.02467 | −0.77 | 1.64. E − 02 | POU domain transcription factor, class 3 | |
| adi_v1.01257 | −2.42 | 2.19. E − 20 | POU domain transcription factor, class 3 | ||
| adi_v1.07955 | −0.79 | 2.33. E − 03 | Polycomb protein EED | ||
| adi_v1.22403 | −1 | 7.30. E − 09 | Transcription factor YY | ||
| adi_v1.05095 | −2.02 | 2.03. E − 30 | Krueppel-like factor 8/12 | ||
| adi_v1.05096 | −4 | 6.58. E − 50 | Kueppel-like factor 5 | ||
| adi_v1.16694 | −3.31 | 4.29. E − 08 | Forkhead box protein C | ||
| adi_v1.24494 | −3.42 | 1.26. E − 27 | Forkhead box protein J1 | ||
| adi_v1.22785 | −3.77 | 1.26. E − 18 | N-Myc proto-oncogene protein | ||
| adi_v1.22791 | −4.83 | 7.54. E − 45 | Myc proto-oncogene protein | ||
| adi_v1.00241 | −3.87 | 1.25. E − 30 | Protein sprouty homolog 1 | ||
| adi_v1.00237 | −7.2 | 6.22. E − 55 | Protein sprouty homolog 1 | ||
| adi_v1.10004 | −4.2 | 4.70. E − 04 | Collagen, type I/II/III/V/XI/XXIV/XXVII, alpha | ||
| adi_v1.09766 | −4.96 | 2.99. E − 05 | Collagen, type I/II/III/V/XI/XXIV/XXVII, alpha | ||
| adi_v1.07457 | −5.64 | 3.38. E − 87 | Homeobox protein DLX, invertebrate | ||
| adi_v1.10929 | −8.3 | 9.30. E − 34 | Homeobox protein GSH | ||
| adi_v1.04989 | −1.34 | 2.33. E − 05 | BTB/POZ domain | ||
| adi_v1.02105 | −2.42 | 4.91. E − 23 | BTB/POZ domain (germ cell-less protein-like 1) | ||
| adi_v1.12091 | −7.52 | 2.80. E − 105 | Hairy and enhancer of split, invertebrate bHLH | ||
| adi_v1.14589 | −6.95 | 4.61. E − 184 | Hairy and enhancer of split, invertebrate bHLH | ||
| adi_v1.00267 | −2.36 | 9.53. E − 14 | SOX group C | ||
| adi_v1.03401 | −3.17 | 6.23. E − 47 | SOX group E/F | ||
| adi_v1.11949 | −3.93 | 5.70. E − 17 | Jagged-1 | ||
| adi_v1.20013 | −3.87 | 4.41. E − 41 | Jagged-2 | ||
| adi_v1.01978 | −3.65 | 2.31. E − 09 | Notch-1 | ||
| adi_v1.14878 | −5.57 | 1.08. E − 05 | Notch-like | ||
| adi_v1.08519 | −3.42 | 1.06. E − 48 | Snail, invertebrate | ||
| adi_v1.11963 | −2.7 | 1.21. E − 36 | Snail, invertebrate | ||
| G vs. S | G | adi_v1.09989 | 7.06 | 7.56. E − 11 | Chromodomain helicase DNA binding protein 8 [EC:3.6.4.12] |
| adi_v1.15318 | 1.09 | 2.53. E − 07 | Chromodomain-helicase-DNA-binding protein 3 [EC:3.6.4.12] | ||
| adi_v1.07285 | 7.88 | 1.41. E − 18 | Chromobox protein 1_polycomb family | ||
| adi_v1.16661 | 4.08 | 5.19. E − 34 | Chromatin modification-related protein EAF7 | ||
| adi_v1.16299 | 3.14 | 1.56. E − 47 | Histone acetyltransferase HTATIP [EC:2.3.1.48] | ||
| adi_v1.12821 | 5.38 | 1.92. E − 91 | BTB/POZ domain-containing protein 3/6 | ||
| adi_v1.12822 | 5.93 | 1.64. E − 97 | BTB/POZ domain-containing protein 3/6 | ||
| adi_v1.13155 | 4.03 | 5.75. E − 29 | WNT inhibitory factor 1 | ||
| adi_v1.21181 | 1.16 | 1.29. E − 06 | WNT inhibitory factor 1 | ||
| adi_v1.01479 | 5.62 | 6.26. E − 65 | Dickkopf | ||
| adi_v1.08519 | 2.54 | 5.04. E − 29 | Snail, invertebrate | ||
| adi_v1.11963 | 2.2 | 2.37. E − 22 | Snail, invertebrate | ||
| adi_v1.20687 | 1.89 | 1.47. E − 06 | Brachyury protein-like | ||
| adi_v1.21035 | 2.16 | 2.14. E − 02 | Forkhead box protein L | ||
| adi_v1.17538 | 2.06 | 3.59. E − 28 | Forkhead box protein N | ||
| adi_v1.14488 | 3.05 | 6.75. E − 08 | Forkhead box protein P | ||
| adi_v1.12738 | −2.65 | 6.42. E − 28 | Chromatin modification-related protein YNG2 | ||
| adi_v1.12357 | −4.46 | 5.16. E − 07 | Histone deacetylase 6/10 [EC:3.5.1.98] | ||
| adi_v1.06801 | −6.33 | 1.11. E − 34 | Chromobox protein 6-polycomb family | ||
| adi_v1.06066 | −5.81 | 5.62 E − 39 | Fibroblast growth factor receptor | ||
| adi_v1.09510 | −4.75 | 8.98 E − 05 | Fibroblast growth factor receptor | ||
| adi_v1.07835 | −4.35 | 5.00 E − 50 | Fibroblast growth factor | ||
| adi_v1.00239 | −3.4 | 6.55 E − 10 | Fibroblast growth factor | ||
| adi_v1.20515 | −2.81 | 1.46 E − 05 | Fibroblast growth factor receptor | ||
| adi_v1.09253 | −6.42 | 2.80. E − 71 | Forkhead box protein L | ||
| adi_v1.00195 | −2.99 | 1.12. E − 33 | Forkhead box P3 | ||
| adi_v1.16190 | −4.68 | 2.93. E − 18 | Forkhead box protein A2 | ||
| adi_v1.10031 | −1.23 | 2.04. E − 05 | Forkhead box protein O3 | ||
| adi_v1.05516 | −4.99 | 8.77. E − 17 | Forkhead box protein P | ||
| adi_v1.16084 | −7.83 | 4.81. E − 26 | SOX group B | ||
| adi_v1.23073 | −8.8 | 8.27. E − 54 | SOX group B | ||
| adi_v1.13187 | −6.19 | 2.18. E − 75 | SOX group E/F | ||
| adi_v1.23415 | −7.46 | 6.02. E − 46 | SOX group E/F | ||
| adi_v1.05035 | −4.57 | 3.38. E − 27 | Transcription factor Sp, invertebrate | ||
| adi_v1.07373 | −2.62 | 2.02. E − 39 | Transcription factor Sp2 | ||
| adi_v1.05034 | −1.13 | 3.32. E − 07 | Transcription factor Sp5 | ||
| adi_v1.02807 | −3.61 | 9.70. E − 03 | Transcription factor Spi-B | ||
| adi_v1.04124 | −0.61 | 1.16. E − 02 | Brachyury protein | ||
| adi_v1.14801 | −2.33 | 9.55. E − 16 | Dishevelled associated activator of morphogenesis | ||
| adi_v1.07373 | −2.62 | 2.02. E − 39 | Transcription factor Sp2 | ||
| adi_v1.05035 | −4.57 | 3.38. E − 27 | Transcription factor Sp, invertebrate | ||
| adi_v1.06348 | −6.71 | 5.51. E − 12 | Homeobox protein HoxA/B2 | ||
| adi_v1.11050 | −6.87 | 1.10. E − 30 | Matrix metalloproteinase-23 (CA-MMP) [EC:3.4.24.-] | ||
| XLOC_003365 | −7 | 7.23. E − 16 | Dishevelled associated activator of morphogenesis | ||
| adi_v1.16084 | −7.83 | 4.81. E − 26 | Transcription factor SOX1/3/14/21 (SOX group B) | ||
| adi_v1.14274 | −7.97 | 4.37. E − 67 | Matrix metalloproteinase-23 (CA-MMP) [EC:3.4.24.-] | ||
| adi_v1.23073 | −8.8 | 8.27. E − 54 | Transcription factor SOX1/3/14/21 (SOX group B) | ||
| adi_v1.06125 | −9.77 | 4.03. E − 59 | Homeobox protein HoxA/B/C6 | ||
| S vs. P | S | adi_v1.19555 | 6.54 | 5.96. E − 06 | Homeobox protein aristaless-related |
| adi_v1.06348 | 6.71 | 1.31. E − 07 | Homeobox protein HoxA/B2 | ||
| adi_v1.05443 | 6.06 | 6.55. E − 45 | Homeobox protein GSH | ||
| adi_v1.16084 | 7.83 | 9.78. E − 16 | Transcription factor SOX1/3/14/21 (SOX group B) | ||
| adi_v1.23415 | 8.91 | 3.87. E − 29 | Transcription factor SOX7/8/9/10/18 (SOX group E/F) | ||
| adi_v1.05035 | 6.03 | 2.00. E − 23 | Transcription factor Sp, invertebrate | ||
| adi_v1.07373 | 3.99 | 5.80. E − 54 | Transcription factor Sp2 | ||
| adi_v1.23437 | 3.68 | 1.07. E − 09 | Alkaline phosphatase [EC:3.1.3.1] | ||
| P | adi_v1.01571 | −1.77 | 6.69. E − 17 | Transcription factor SOX1/3/14/21 (SOX group B) | |
| adi_v1.00157 | −1.75 | 2.16. E − 17 | Transcription factor Sp, invertebrate | ||
| adi_v1.05150 | −3.46 | 7.32. E − 38 | Transcription factor Sp, invertebrate | ||
| XLOC_010624 | −6.25 | 1.17. E − 06 | Homeobox protein MOX | ||
| adi_v1.20693 | −4.12 | 2.09. E − 27 | Homeobox protein aristaless-like 4 | ||
| adi_v1.00574 | −3.94 | 1.44. E − 05 | PAX 3/7/D | ||
| adi_v1.06991 | −5.37 | 1.02. E − 25 | PAX 3/7 | ||
| adi_v1.22792 | −1.4 | 1.30. E − 06 | Myc proto-oncogene protein | ||
| adi_v1.22785 | −1.67 | 1.85. E − 09 | Myc proto-oncogene protein | ||
| adi_v1.20978 | −1.79 | 1.47. E − 03 | Transcription factor AP-2, invertebrate | ||
| adi_v1.15539 | −2.77 | 1.38. E − 35 | Transcription factor AP-1 | ||
| adi_v1.04124 | −1.18 | 2.42. E − 07 | Brachyury protein | ||
| adi_v1.13155 | −2.8 | 5.28. E − 10 | WNT inhibitory factor 1 | ||
| adi_v1.21181 | −0.58 | 1.92. E − 02 | WNT inhibitory factor 1 | ||
| adi_v1.16974 | −1.05 | 1.35. E − 05 | Bone morphogenetic protein receptor type-2 [EC:2.7.11.30] | ||
| adi_v1.15796 | −5.77 | 1.63. E − 05 | Bone morphogenetic protein 2/4_isoform | ||
| adi_v1.12454 | −1.11 | 1.96. E − 02 | Frizzled 10-like | ||
| adi_v1.12455 | −4.25 | 1.73. E − 104 | Frizzled 8-like | ||
| P vs. A | P | adi_v1.12103 | 1.92 | 1.97. E − 07 | Chromobox protein 2 |
| adi_v1.24534 | 1.79 | 1.04. E − 16 | Chromodomain-helicase-DNA-binding protein 4 [EC:3.6.4.12] | ||
| adi_v1.18668 | 6.35 | 1.47. E − 07 | Chromobox protein 6 | ||
| adi_v1.06504 | 2.15 | 4.74. E − 09 | Calmodulin-like5 | ||
| adi_v1.01102 | 1.4 | 2.93. E − 08 | Calmodulin CaM | ||
| adi_v1.05564 | 1.13 | 1.66. E − 02 | Calmodulin-like4 | ||
| XLOC_013827 | 0.93 | 1.60. E − 05 | Calmodulin-7 | ||
| adi_v1.03833 | 0.73 | 9.25. E − 03 | Calmodulin-8 | ||
| A | adi_v1.20187 | −2.32 | 8.44. E − 06 | Histone-lysine N-methyltransferase MLL1 [EC:2.1.1.43] | |
| adi_v1.12357 | −2.4 | 2.49. E − 03 | Histone deacetylase 6/10 [EC:3.5.1.98] | ||
| adi_v1.01196 | −1.07 | 2.30. E − 04 | Polycomb group RING finger protein 3 | ||
| adi_v1.19438 | −1.46 | 8.88. E − 03 | Polycomb group RING finger protein 5 | ||
| adi_v1.09632 | −1.93 | 2.77. E − 11 | Polycomb protein SCMH1 | ||
| adi_v1.10053 | −1.62 | 1.01. E − 03 | Polycomb protein SCMH1 | ||
| adi_v1.14017 | −1.22 | 5.58. E − 06 | Polycomb protein SCMH1 | ||
| adi_v1.00878 | −1.45 | 4.39. E − 06 | Polycomb protein SUZ12 | ||
| adi_v1.16355 | −0.97 | 3.58. E − 03 | Carbonic anhydrase [EC:4.2.1.1] | ||
| adi_v1.11313 | −2.61 | 9.17. E − 10 | Carbonic anhydrase [EC:4.2.1.1] |
UP regulation in each stage shown. Transcripts shown in this table were selected based on: 1) significant P values (0.05 cutoff value) and 2) evidence in the literature of their involvement in the regulation of developmental processes. A complete list of DEGs can be found in supplementary file S3, Supplementary Material online.
FCoexpression gene networks. Transcripts (18,264) were assigned to 37 different gene modules that ranged from 30 to 3,400 transcripts and grouped in three main coexpression clusters. In some cases modules were differentially expressed between two stages indicating negative/positive regulation of specific processes at different developmental time points. Eigengenes were calculated for each module and although we were able to identify discrete gene expression patterns, in most cases significant module-trait correlation were observed in a stage specific fashion. * P value ≤0.05, ** P value ≤0.01, *** P value ≤0.001.
GO Enrichment Summary in WGCNA
| Stage | GO ID | Node size | Sample match | P adj | Term | |
|---|---|---|---|---|---|---|
| WGCN clusters’ GO enrichment | PC | GO:0034660 | 1571 | 341 | 0.0030 | ncRNA metabolic process |
| GO:0007049 | 6345 | 1270 | 0.0082 | Cell cycle | ||
| GO:2000036 | 26 | 10 | 0.0165 | Regulation of stem cell maintenance | ||
| GO:0048866 | 8 | 4 | 0.0477 | Stem cell fate specification | ||
| GO:0006349 | 77 | 28 | 0.0002 | Regulation of genetic imprinting | ||
| GO:0043697 | 12 | 6 | 0.0152 | Cell dedifferentiation | ||
| GO:0040034 | 125 | 35 | 0.0093 | Regulation of development, heterochronic | ||
| GO:0001510 | 321 | 93 | 0.0000 | RNA methylation | ||
| GO:0043045 | 49 | 18 | 0.0028 | DNA methylation involved in embryo development | ||
| GO:0097198 | 14 | 6 | 0.0351 | Histone H3-K36 trimethylation | ||
| GO:0061085 | 16 | 7 | 0.0205 | Regulation of histone H3-K27 methylation | ||
| GO:0034401 | 84 | 24 | 0.0219 | Regulation of transcription by chromatin organization | ||
| GO:0070870 | 4 | 3 | 0.0236 | Heterochromatin maintenance chromatin silencing | ||
| GO:0006338 | 476 | 113 | 0.0050 | Chromatin remodeling | ||
| GO:0036093 | 23 | 9 | 0.0201 | Germ cell proliferation | ||
| GO:0016332 | 41 | 15 | 0.0064 | Maintenance of polarity of embryonic epithelium | ||
| GO:0002070 | 38 | 12 | 0.0447 | Epithelial cell maturation | ||
| GO:0044334 | 6 | 4 | 0.0141 | Wnt signaling pathway regulation of epithelial transition | ||
| GO:0008543 | 439 | 101 | 0.0196 | Fibroblast growth factor receptor signaling pathway | ||
| G | GO:0001703 | 95 | 16 | 0.0051 | Gastrulation with mouth forming first | |
| GO:0046529 | 77 | 14 | 0.0043 | Imaginal disc fusion, thorax closure | ||
| GO:0003384 | 18 | 6 | 0.0026 | Apical constriction involved in gastrulation | ||
| GO:0048615 | 10 | 3 | 0.0446 | Embryonic anterior midgut (ectodermal) morphogenesis | ||
| GO:0007370 | 44 | 11 | 0.0008 | Ventral furrow formation | ||
| GO:0045919 | 29 | 8 | 0.0020 | Positive regulation of cytolysis | ||
| GO:1902337 | 11 | 4 | 0.0099 | Apoptotic process involved in morphogenesis | ||
| GO:0045167 | 85 | 15 | 0.0042 | Protein localization involved in cell fate determination | ||
| GO:0097193 | 491 | 57 | 0.0065 | Intrinsic apoptotic signaling pathway | ||
| GO:0007191 | 48 | 13 | 0.0001 | Dopamine receptor signaling pathway | ||
| GO:0030521 | 128 | 20 | 0.0046 | Androgen receptor signaling pathway | ||
| GO:0042921 | 16 | 5 | 0.0080 | Glucocorticoid receptor signaling pathway | ||
| GO:0048384 | 40 | 7 | 0.0455 | Retinoic acid receptor signaling pathway | ||
| GO:0007210 | 82 | 12 | 0.0384 | Serotonin receptor signaling pathway | ||
| GO:0006836 | 627 | 65 | 0.0399 | Neurotransmitter transport | ||
| GO:0043409 | 421 | 45 | 0.0490 | Negative regulation of MAPK cascade | ||
| GO:0016360 | 36 | 7 | 0.0271 | Sensory organ precursor cell fate determination | ||
| GO:0030218 | 336 | 38 | 0.0339 | Erythrocyte differentiation | ||
| GO:0070849 | 81 | 12 | 0.0358 | Response to epidermal growth factor | ||
| GO:0006122 | 17 | 4 | 0.0477 | Electron transport, ubiquinol to cytochrome c | ||
| GO:0015980 | 1031 | 107 | 0.0105 | Energy derivation by oxidation of organic compounds | ||
| GO:0051901 | 32 | 9 | 0.0009 | Positive regulation of mitochondrial depolarization | ||
| GO:0016042 | 765 | 87 | 0.0018 | Lipid catabolic process | ||
| GO:0005996 | 688 | 87 | 4.21 E − 05 | Monosaccharide metabolic process | ||
| S | GO:0001510 | 298 | 76 | 0.0003 | RNA methylation | |
| GO:0034660 | 914 | 184 | 0.0157 | ncRNA metabolic process | ||
| GO:0007530 | 188 | 43 | 0.0364 | Sex determination | ||
| GO:0009994 | 523 | 107 | 0.0473 | Oocyte differentiation | ||
| GO:0048232 | 1123 | 232 | 0.0035 | Male gamete generation | ||
| GO:0045815 | 78 | 24 | 0.0031 | Positive regulation of gene expression, epigenetic | ||
| GO:0016441 | 566 | 115 | 0.0487 | Post-transcriptional gene silencing | ||
| GO:0007601 | 494 | 108 | 0.0079 | Visual perception | ||
| GO:0009785 | 21 | 8 | 0.0211 | Blue light signaling pathway | ||
| GO:0009639 | 61 | 17 | 0.0297 | Response to red or far red light | ||
| GO:0048665 | 88 | 25 | 0.0081 | Neuron fate specification | ||
| GO:0021587 | 126 | 32 | 0.0172 | Cerebellum morphogenesis | ||
| GO:0048854 | 181 | 43 | 0.0210 | Brain morphogenesis | ||
| GO:0021692 | 34 | 11 | 0.0269 | Cerebellar Purkinje cell layer morphogenesis | ||
| GO:0021527 | 24 | 8 | 0.0469 | Spinal cord association neuron differentiation | ||
| GO:0031987 | 128 | 31 | 0.0351 | Locomotion involved in locomotory behavior | ||
| GO:0021692 | 124 | 31 | 0.0233 | Mechanosensory behavior | ||
| GO:0009950 | 191 | 47 | 0.0087 | Dorsal/ventral axis specification | ||
| GO:0048263 | 40 | 14 | 0.0063 | Determination of dorsal identity | ||
| GO:0060811 | 97 | 26 | 0.0152 | imRNA localization anterior/posterior axis specification | ||
| GO:2000738 | 14 | 6 | 0.0245 | Positive regulation of stem cell differentiation | ||
| GO:0045165 | 1858 | 355 | 0.0387 | Cell fate commitment | ||
| GO:0003263 | 8 | 5 | 0.0059 | Cardioblast proliferation | ||
| GO:0061325 | 37 | 13 | 0.0080 | Cell proliferation involved tract morphogenesis | ||
| GO:0016055 | 1123 | 224 | 0.0190 | Wnt signaling pathway | ||
| GO:0000188 | 54 | 16 | 0.0205 | Inactivation of MAPK activity | ||
| GO:0046426 | 56 | 16 | 0.0286 | Negative regulation of JAK-STAT cascade | ||
| GO:0007173 | 643 | 131 | 0.0350 | Epidermal growth factor receptor signaling pathway | ||
| GO:0032502 | 12791 | 2291 | 0.0327 | Developmental process | ||
| GO:0048611 | 10 | 5 | 0.0193 | Embryonic ectodermal digestive tract development | ||
| GO:0002119 | 798 | 167 | 0.0073 | Nematode larval development | ||
| GO:0007394 | 15 | 6 | 0.0348 | Dorsal closure, elongation of leading edge cells | ||
| GO:0019954 | 831 | 83 | 0.0000 | Asexual reproduction | ||
| GO:0007276 | 3318 | 228 | 0.0441 | Gamete generation | ||
| P | GO:0019953 | 778 | 67 | 0.0023 | Sexual reproduction | |
| GO:0036166 | 80 | 16 | 0.0000 | Phenotypic switching | ||
| GO:0010172 | 179 | 18 | 0.0294 | Embryonic body morphogenesis | ||
| GO:0009949 | 36 | 6 | 0.0221 | Polarity specification of anterior/posterior axis | ||
| GO:0010085 | 13 | 3 | 0.0426 | Polarity specification of proximal/distal axis | ||
| GO:0008258 | 164 | 20 | 0.0029 | Head involution | ||
| GO:0048580 | 238 | 23 | 0.0205 | Regulation of postembryonic development | ||
| GO:0042488 | 40 | 10 | 0.0001 | Regulation of odontogenesis of dentin-containing tooth | ||
| GO:0030860 | 116 | 15 | 0.0054 | Regulation of polarized epithelial cell differentiation | ||
| GO:0042481 | 77 | 10 | 0.0202 | Regulation of odontogenesis | ||
| GO:0045880 | 104 | 12 | 0.0273 | Positive regulation of smoothened signaling pathway | ||
| GO:0035481 | 4 | 2 | 0.0212 | Positive regulation of Notch signaling pathway | ||
| GO:0031930 | 20 | 5 | 0.0064 | Mitochondria-nucleus signaling pathway | ||
| GO:0008543 | 374 | 40 | 0.0005 | Fibroblast growth factor receptor signaling pathway | ||
| GO:0007173 | 385 | 40 | 0.0008 | Epidermal growth factor receptor signaling pathway | ||
| GO:0060853 | 6 | 2 | 0.0487 | Notch signaling pathway involved in cell commitment | ||
| GO:0038032 | 152 | 19 | 0.0028 | t G-protein coupled receptor signaling pathway | ||
| GO:0008277 | 498 | 45 | 0.0073 | G-protein coupled receptor protein signaling pathway | ||
| GO:1901297 | 3 | 2 | 0.0110 | Wnt signaling pathway involved in cell fate commitment | ||
| GO:0016441 | 566 | 52 | 0.0030 | Post-transcriptional gene silencing | ||
| GO:0030466 | 155 | 17 | 0.0158 | Chromatin silencing at silent mating-type cassette | ||
| GO:0022008 | 5808 | 405 | 0.0022 | Neurogenesis | ||
| GO:0045165 | 1858 | 135 | 0.0274 | Cell fate commitment | ||
| GO:0007626 | 1158 | 87 | 0.0350 | Locomotory behavior | ||
| A | GO:0009059 | 10086 | 632 | 0.0414 | Macromolecule biosynthetic process | |
| GO:0006006 | 881 | 76 | 0.0008 | Glucose metabolic process | ||
| GO:0009060 | 256 | 25 | 0.0112 | Aerobic respiration | ||
| GO:2001171 | 6 | 3 | 0.0037 | Positive regulation of ATP biosynthetic process | ||
| GO:0051280 | 9 | 3 | 0.0137 | Negative release of sequestered calcium into cytosol | ||
| GO:0051562 | 9 | 3 | 0.0137 | Negative regulation of mitochondrial calcium ion | ||
| GO:0051926 | 28 | 5 | 0.0237 | Negative regulation of calcium ion transport | ||
| GO:0046534 | 32 | 5 | 0.0400 | Positive regulation of photoreceptor cell differentiation | ||
| GO:0042304 | 59 | 8 | 0.0237 | Regulation of fatty acid biosynthetic process | ||
| GO:0016042 | 765 | 60 | 0.0196 | Lipid catabolic process | ||
| GO:0060290 | 10 | 3 | 0.0187 | Transdifferentiation | ||
| GO:0043046 | 9 | 3 | 0.0137 | DNA methylation involved in gamete generation | ||
| GO:0035093 | 8 | 3 | 0.0096 | Spermatogenesis, exchange of chromosomal proteins | ||
| GO:0002478 | 603 | 47 | 0.0389 | Presentation of exogenous peptide antigen | ||
| GO:0051023 | 55 | 8 | 0.0160 | Regulation of immunoglobulin secretion | ||
| GO:0044029 | 2 | 2 | 0.0036 | Hypomethylation of CpG island | ||
| GO:0071514 | 88 | 11 | 0.0156 | Genetic imprinting | ||
| GO:0000183 | 48 | 7 | 0.0230 | Chromatin silencing at rDNA | ||
| GO:0044337 | 8 | 3 | 0.0096 | Wnt signaling pathway in regulation of apoptotic | ||
| GO:0032483 | 90 | 13 | 0.0027 | Regulation of Rab protein signal transduction | ||
| GO:0038096 | 282 | 27 | 0.0110 | Fc-gamma receptor signaling pathway | ||
| GO:0033209 | 123 | 13 | 0.0328 | Tumor necrosis factor-mediated signaling pathway | ||
| GO:0042753 | 42 | 6 | 0.0377 | Positive regulation of circadian rhythm | ||
| GO:0070257 | 8 | 3 | 0.0096 | Positive regulation of mucus secretion | ||
| GO:0003331 | 18 | 5 | 0.0034 | Regulation of extracellular matrix constituent secretion | ||
| GO:0070278 | 23 | 4 | 0.0451 | Extracellular matrix constituent secretion | ||
| GO:0009101 | 962 | 80 | 0.0018 | Glycoprotein biosynthetic process | ||
| GO:0018279 | 185 | 20 | 0.0077 | Protein N-linked glycosylation via asparagine | ||
| GO:0018242 | 16 | 4 | 0.0130 | Protein O-linked glycosylation via serine | ||
| GO:0006891 | 134 | 14 | 0.0300 | Intra-Golgi vesicle-mediated transport | ||
| GO:0032956 | 1041 | 76 | 0.0416 | Regulation of actin cytoskeleton organization |
Enriched in Cluster shown in column. Node size= Total number GO terms in node. Sample match= number of transcripts with GO terms associated to specific nodes. GO categories shown in this table were selected based on: 1) significant P values (0.05 cutoff value) and 2) evidence in the literature of their involvement in the regulation of developmental processes. A complete list of enriched GO categories can be found in supplementary file S4, Supplementary Material online.